FDA Inspection
Centaur Pharmaceuticals Private LimitedCentaur Pharmaceuticals Private Limited – FDA Inspection, Jan 13, 2023
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Limited, with an inspection on January 13, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- January 13, 2023
View Company Profile
ID · f92de877-2291-4ba5-8c40-c39fd827d609
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1195193
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.110(b)In-process specification, invalid
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Centaur Pharmaceuticals Private Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Centaur Pharmaceuticals Private Limited
- FDA Inspection 1297060 - 2025-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.